Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Inflamm Bowel Dis. 2017 Jan;23(1):107–115. doi: 10.1097/MIB.0000000000000977

Table 1. Demographic and clinical characteristics of Crohn's disease patients (n =243) included in the study.

Total n =243

Females, n (%) 141 (58)

Age (years), median (IQR) 44 (34-56)

Caucasian ethnicity, n (%) 235 (96.7)

BMI (kg/m2), median (IQR) 25.1 (22.2-28.6)

Smoking, n (%)
 Never 123 (50.9)
 Former 41 (16.9)
 Current 78 (32.2)

Age at diagnosis (years), median (IQR) 28 (23-38)

Disease duration (years), median (IQR) 12 (7-19)

Disease location (as per Montreal classification (18), n (%)
 L1 (ileal) 57 (23.5)
 L2 (colonic) 51 (20.9)
 L3 (ileocolonic) 134 (55)
 L4 (isolated upper digestive) 1 (0.4)

Disease behavior (as per Montreal classification (18), n (%)
 B1 (non stricturing, non penetrating) 84 (34.6)
 B2 (stricturing) 72 (29.6)
 B3 (penetrating) 48 (19.8)
 P (perianal disease) 39 (16.1)

CRS prior to study, n (%) 175 (72)

CRS during the study, n (%) 102 (42)

Psychiatrics co-morbidities, n (%) 78 (32)

LI1, median (IQR) 8.3 (1.3-12.3)

LI2, median (IQR) 8.9 (2.5-20.6)

DLI, median (IQR) 0.4 (0-3.8)

Months between LI1 and LI2, median (IQR) 48 (42-55)

5y SIBDQ, median (IQR) 50 (40-58)

5y HBI, median (IQR) 4.2 (2-7.2)

n: number of patients; IQR: interquartile range; BMI: Body Mass Index; CRS: Crohn's disease related surgery (both outpatient and inpatient); LI1: Lémann Index 1; LI2: Lémann index 2; DLI: Delta Lémann Index; SIBDQ: Short inflammatory bowel disease questionnaire; HBI: Harvey Bradshaw Index y: years